The impact of the ursodeoxycholic acid as monotherapy and in the combination with the lactulose on the biochemical blood tests values of the nonalcoholic steatohepatitis patients
Aim of the Study. The administration of ursodeoxycholic acid (UDCA) as monotherapy or in combination with lactulose for the treatment of the patients with nonalcoholic steatohepatitis (NASH) has been studied insufficiently. The aim was to assess the impact of the 90-day therapy with Ursoliv® drug (2...
Saved in:
Main Authors: | I. V. Mayev, Yu. A. Kucheryavyy, S. V. Morozov, M. G. Saidullayeva, M. L. Akhtayeva, N. Yu. Stukova, E. A. Krasnyakova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Gastro LLC
2013-03-01
|
Series: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
Subjects: | |
Online Access: | https://www.gastro-j.ru/jour/article/view/1184 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Application of ursodeoxycholic acid at non-alcoholic and alcohol-induced steatohepatitis
by: Ye. A. Fedos’ina, et al.
Published: (2010-06-01) -
CISD2-mediated mitochondrial dysfunction and iron redistribution contributes to ferroptosis in arsenic-induced nonalcoholic steatohepatitis
by: Jingyuan Zhang, et al.
Published: (2025-01-01) -
Association of nonalcoholic fatty liver disease and growth hormone deficiency: a systematic review and meta-analysis
by: Tingting Kong, et al.
Published: (2023-10-01) -
Ursodeoxycholic acid in complex treatment of metabolic syndrome
by: O. A. Tanchenko, et al.
Published: (2012-02-01) -
Modern Possibilities of Using Lactulose in Clinical Practice
by: A. A. Sheptulin
Published: (2023-11-01)